Skip to main content
. 2014 May 27;124(1):42–48. doi: 10.1182/blood-2014-02-555722

Table 2.

Kaplan-Meier estimates for TT and OS by risk factor

Biomarker TT OS
Median, y 95% CI Median, y 95% CI
Methylation, <20% 2.9 2.0-3.3 9.1 8.0-11.1
Methylation, ≥20% 6.5 5.4-9.0 17.5 16.7-NR
M-IGHV 6.3 4.5-8.0 16.7 12.1-22.7
U-IGHV 2.9 2.1-3.4 9.1 8.0-11.0
CD38 4.4 3.7-5.6 12.0 9.1-16.7
CD38+ 2.8 1.9-3.4 9.7 8.4-12.2
ZAP-70 5.5 4.2-6.9 16.7 12.1-22.7
ZAP-70+ 2.1 1.7-2.9 8.8 7.8-9.9

M-IGHV, IGHV mutated; NR, not reached; U-IGHV, IGHV unmutated.